Market Overview

UPDATE: Bio-Techne Acquisition To Be Financed Through Combination Of Cash On Hand And A Revolving Line Of Credit Facility That Co. Expects To Obtain Prior To Closing Of Deal

Share:

This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Posted-In: News M&A

 

Related Articles (TECH)

Markets Still Spooked By Trade Fears; Tech Sector Leads Stocks Lower

Cantor Fitzgerald Raises GW Pharma's Target To $235 Following Epidiolex Approval